Angiotensin II blockade and aortic-root dilation in Marfan's syndrome - Wikidata - wikimedia - TriplyDB

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

http://www.wikidata.org/entity/Q28285199

about

First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection First-line beta-blockers versus other anti-hypertensive medications for chronic type B aortic dissections Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.Aortic Aneurysm: Etiopathogenesis and Clinicopathologic Correlations Marfan syndrome: current perspectives Recent discoveries and emerging therapeutics in eosinophilic esophagitis Mitral valve disease--morphology and mechanisms.Short and tall stature: a new paradigm emerges Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions Defining the extracellular matrix using proteomics Aneurysms of the ascending aorta Educational paper. Connective tissue disorders with vascular involvement: from gene to therapy Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome Vascular proteomics in metabolic and cardiovascular diseases Repurposing of approved cardiovascular drugs Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis Marfan syndrome: An eyesight of syndrome Mutations in LRPAP1 are associated with severe myopia in humans Ang II enhances noradrenaline release from sympathetic nerve endings thus contributing to the up-regulation of metalloprotease-2 in aortic dissection patients' aorta wall Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia Current themes in molecular pediatrics: molecular medicine and its applications.Comparative measurement of aortic root by transthoracic echocardiography in normal Korean population based on two different guidelines Metachronous bilateral posterior tibial artery aneurysms in Ehlers-Danlos syndrome type IV.Cardiovascular magnetic resonance in Marfan syndrome.Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection.Thrombocytopenia: an early marker of late mortality in type B aortic dissection.Biogenesis and function of fibrillin assemblies.Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial Extracellular matrix molecules: potential targets in pharmacotherapy.Recapitulating and Correcting Marfan Syndrome in a Cellular Model.Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.The Genetics of Aortopathies in Clinical Cardiology.Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome Topiramate use does not reduce flares of inflammatory bowel disease Coronary artery abnormalities in Hyper-IgE syndrome The endothelium: paracrine mediator of aortic dissection Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.

P2860

Q24200255-0722D1B3-79E7-409B-9EE7-D163247F04D7 Q24200438-79C275AE-58AA-4035-9D31-48794CB2A9A0 Q24300318-9AD1932D-95C0-490D-9157-DA72229E3930 Q24306115-1849036F-09C0-4143-BABE-4265A1F0A186 Q26744537-8C7ED458-0995-488B-8157-3F6AE615D594 Q26744820-B50ED542-6FF9-4FFB-A68F-C4098BFC45BB Q26747739-F75D217F-7A05-4AB0-A82B-3F07871B61F4 Q26768277-4C1C110F-17D8-41E0-BE92-A381C0B0001C Q26781699-49156477-58B9-420F-94D5-D1DA9A131538 Q26781983-0D46AE1B-5CCF-49B2-BD5B-3F719E9A6E68 Q26823452-9BD8E059-25EE-4EFC-85D5-31E52D0C64E1 Q26823672-008AED93-016B-468B-838F-4D1790A55E4F Q26830221-7F7993C1-3ED0-402F-8CD9-2628C162FA37 Q26830657-28A4A36B-B16F-4750-BFA1-25448952017F Q26853455-DEB116F7-D40A-4570-B242-370DC7948822 Q26864278-BBA68FAC-F775-48EA-B244-3BFD65EDBB51 Q28070315-E6E98446-72EC-4C52-A284-D45E2AF62D85 Q28074453-F9D545F6-E438-46FF-8297-67EF39F09444 Q28240167-CB32DC88-0C05-4C94-8572-F77A1F99FD20 Q28255763-7501C10B-93E3-4DE2-B579-9A1118ACC736 Q28294040-9415F0D1-CCB4-4338-B387-32C97A1C9181 Q28534594-E2EC411A-9448-421D-A9A4-1E107752F159 Q28590927-468C343C-CB9F-4E19-A145-B09891E19841 Q30397005-EE838F30-AF71-4ED7-9D50-6864F05416A5 Q30450362-F004C239-102E-4476-9AD0-59E69B527A0D Q30451248-DAE4C342-7972-42E7-A64F-593C49C33AED Q30454633-B2C02ED5-C30B-428B-8EC7-403BD7FD12C6 Q30842247-C050F97A-C951-4D63-99BD-E83DD5076412 Q33407180-1ABC3AF6-A272-457E-AB65-5DC5639ED82F Q33641386-412C9F84-CAC7-4596-B538-CE2F5A56344F Q33692258-51747420-0894-40B4-A946-D45F8D93BE5C Q33694487-4802543C-B623-4A89-ABDD-26B43D326BCC Q33717760-4EE17790-7B22-4D91-A0B6-7916B4A07EB5 Q33738515-A8B8E5A9-29DC-42AE-9FBF-D97443BB004A Q33758342-5E2723C4-6E4E-4BE3-B05A-B81BC63344D2 Q33776426-85A83809-D99B-4551-85A4-C82BA935C11E Q33807261-E7DB51AD-D2FE-4DE5-893B-60860A1C20C6 Q33878509-6C3D22AE-3A1F-458A-BDA2-FC9E425849D2 Q33910996-0F94AAC0-B5F6-40E1-8060-E36F3FDCD772 Q33999588-8C7D19ED-518D-41F0-AAD4-7B0EBA9052B8

P2860

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

http://www.wikidata.org/entity/Q28285199

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@ast

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@en

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@nl

type

label

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@ast

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@en

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@nl

prefLabel

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@ast

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@en

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@nl

P1433

Q28285199-1AF6F0B8-ADA4-4997-A02C-C5667239D8C4

P1476

Q28285199-07580AAF-61BE-4B51-8DC0-1D36240981DB

P2093

Q28285199-1FFC73B1-9330-4B5D-9A4B-BCFE03B79A2D

Q28285199-4639CCF9-4E99-4B69-8F39-A3F2ABE84169

Q28285199-776E251E-09FE-4E5C-9154-17C20CF7EDFE

Q28285199-A1EC1E05-92FB-4164-81CC-9E0DAFF12DB5

Q28285199-B01C2028-1D4B-4AD4-B2BB-E269A70A3A5C

P2860

Q28285199-0344BD03-0F22-4876-AACD-12C663813A2D

Q28285199-07787A04-2F2F-4200-A69C-80017F8A8283

Q28285199-08EE8900-F406-4746-A514-E8F4A31ABBAA

Q28285199-0ED99028-9738-4DAA-B617-C6EFD80E4F81

Q28285199-10D24359-8020-4050-B799-A59E818A0973

Q28285199-21094683-7034-418C-8CE3-B370553D7DB9

Q28285199-39975BDE-C9A5-4095-B6FE-43C7829BF656

Q28285199-4808FB2F-2C57-4511-806F-7E30E34A2A1C

Q28285199-500C72FE-94A5-49D8-A5A8-3B76D75A273D

Q28285199-6444840C-B4FF-41DB-A7F6-5C472B4B8CB6

P304

Q28285199-851B1254-7A66-4DF3-A8B0-EE219CD88ECC

P31

Q28285199-30F9AAAE-B2D0-44A8-B976-A42F936ED229

P3181

Q28285199-CB55C453-D71A-47EF-A092-FF191837C981

P356

Q28285199-B1D53800-705F-4F31-B0ED-06E5325D7C1A

P407

Q28285199-B8361967-29A4-4AD8-A30A-C80F5DB46F4C

P433

Q28285199-5B41007B-88AB-40EF-91E3-03D6FA89B47E

P478

Q28285199-7B25F515-8412-464F-BC31-8C8A31D67C42

P50

Q28285199-7140DE16-F276-41B7-AC2F-D06DE60DB5BB

P577

Q28285199-2ED373FD-2097-4951-9FB4-CD67016414AC

P698

Q28285199-238291D8-F7EA-4FD4-9147-404CC199EF78

P921

Q28285199-659549FC-83B8-48AF-84F2-A64CD2B2BCB6

P932

Q28285199-875F20C8-9051-478F-BDD9-3D2C4C0D9103

P3181

P356

P1433

The New England Journal of Medicine

P1476

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

@en

P2093

Benjamin S Brooke

http://www.w3.org/2001/XMLSchema#string

Daniel P Judge

http://www.w3.org/2001/XMLSchema#string

Harry C Dietz

http://www.w3.org/2001/XMLSchema#string

Jennifer P Habashi

http://www.w3.org/2001/XMLSchema#string

Nishant Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of aortic disease in patients with Marfan syndrome

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Marfan's syndrome

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

Longitudinal data analysis for discrete and continuous outcomes

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Angiotensin II type 1 receptor blockers.

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.

P304

2787-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1364000

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0706585

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18579813

http://www.w3.org/2001/XMLSchema#string

P921

P932

2692965

http://www.w3.org/2001/XMLSchema#string